FDA Alerts & Warnings

Libipower Plus

Product recalled because samples were found to contain undeclared Tadalalafil, an active ingredient of FDA approved drugs for Erectile Dysfunction. Tadalalafil may interact with nitrates found in some prescription drugs such as nitroglycerin, and may lower blood pressure to dangerous levels.

Continue reading...

Immunosuppressant Drugs: Required Labeling Changes

FDA requiring manufacturers of immunosuppressant drugs to update their prescribing information to include stronger warnings about the risk of BK virus-associated nephropathy.

Continue reading...